Last reviewed · How we verify
Treamid once a day
At a glance
| Generic name | Treamid once a day |
|---|---|
| Sponsor | PHARMENTERPRISES LLC |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19 (PHASE2, PHASE3)
- Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia (PHASE2)
- Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Treamid once a day CI brief — competitive landscape report
- Treamid once a day updates RSS · CI watch RSS
- PHARMENTERPRISES LLC portfolio CI